About the study The phase 3a, multicenter, randomized, double-blind, placebo- and active-controlled REDEFINE 1 trial enrolled 3,417 adults across 22 countries
No controlled study has compared once-daily versus twice-daily dosing in humans
The presence of BPC-157 might have led to an increased expression of VEGF-a, a variant of VEGF, and consequently accelerated the formation of vascular tubes in a laboratory setting
Selank has been shown to normalize the production of key cytokines, including IL-6 and interferon-gamma, both of which play central roles in lupus pathology
By integrating BPC-157 thoughtfully into your wellness routine, you can experience faster tissue regeneration, reduced inflammation, and improved recovery times without the need for steroids, surgery, or downtime